Firstly, we validated the inhibitory efficiency of SMAD3i in melanoma cells since it decreased the levels of phospho‐SMAD3 Ser423/425 induced by TGFβ (Fig 5J) in accordance with previous studies (Jinnin et al,2006; Chihara et al,2017). Here, TGFB1 is linked to melanoma.